$RHE
Regional Health Properties Inc Stock $rhe

$rhe Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000100472417000078 Filed on November 14, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$6.360M	$6.345M	$7.165M
YoY Change	7.25%	-11.44%	16.88%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.150M	$3.230M	$3.770M
YoY Change	-12.74%	-14.32%	-2.08%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.370M	$1.193M	$1.124M
YoY Change	22.32%	6.14%	-41.18%
% of Gross Profit
Operating Expenses	$5.100M	$4.944M	$5.139M
YoY Change	8.74%	-3.79%	-15.34%
Operating Profit		$1.401M	$2.026M
YoY Change		-30.85%	3276.67%
Interest Expense	-$1.050M	$1.011M	$1.801M
YoY Change	-30.46%	-43.86%	-1.58%
% of Operating Profit		72.16%	88.89%
Other Income/Expense, Net	-$90.00K	-$1.116M	-$1.801M
YoY Change	350.0%	-38.03%	-14.16%
Pretax Income	$140.0K	$285.0K	$225.0K
YoY Change	-98.29%	26.67%	-111.04%
Income Tax	-$210.0K	$19.00K	$3.000K
% Of Pretax Income	-150.0%	6.67%	1.33%
Net Earnings	$710.0K	-$766.0K	-$1.988M
YoY Change	-51.37%	-61.47%	-58.68%
Net Earnings / Revenue	11.16%	-12.07%	-27.75%
Basic Earnings Per Share			-$0.19
Diluted Earnings Per Share	$432.9K	-$466.7K	-$1.199M
COMMON SHARES
Basic Shares Outstanding	19.76M shares	19.76M	19.92M shares
Diluted Shares Outstanding		19.76M	19.92M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.800M	$1.100M	$1.500M
YoY Change	-87.14%	-26.67%	-65.12%
Cash & Equivalents	$1.818M	$1.115M	$1.457M
Short-Term Investments
Other Short-Term Assets	$2.000M	$2.400M	$53.70M
YoY Change	-50.0%	-95.53%	114.8%
Inventory
Prepaid Expenses
Receivables	$945.0K	$1.086M	$3.327M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.704M	$4.545M	$58.53M
YoY Change	-77.02%	-92.24%	45.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$81.21M	$82.44M	$79.32M
YoY Change	2.58%	3.93%	-37.91%
Goodwill	$2.105M	$2.105M	$2.105M
YoY Change	0.0%	0.0%	-49.68%
Intangibles	$23.30M	$23.54M	$24.89M
YoY Change	-5.09%	-5.42%	-33.24%
Long-Term Investments
YoY Change
Other Assets	$542.0K	$6.407M	$3.855M
YoY Change	5.45%	66.2%	43.31%
Total Long-Term Assets	$101.8M	$102.7M	$95.78M
YoY Change	2.86%	7.18%	-36.08%
TOTAL ASSETS
Total Short-Term Assets	$4.704M	$4.545M	$58.53M
Total Long-Term Assets	$101.8M	$102.7M	$95.78M
Total Assets	$106.6M	$107.2M	$154.3M
YoY Change	-10.83%	-30.53%	-18.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.386M	$3.617M	$4.041M
YoY Change	44.42%	-10.49%	-64.07%
Accrued Expenses	$7.000M	$8.600M	$4.278M
YoY Change	-22.88%	101.03%	-44.93%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$8.300M	$51.20M
YoY Change		-83.79%	2.61%
Long-Term Debt Due	$8.090M	$8.300M	$19.20M
YoY Change	-38.5%	-56.77%	-51.02%
Total Short-Term Liabilities	$19.50M	$20.53M	$61.33M
YoY Change	-22.84%	-66.53%	-10.97%
LONG-TERM LIABILITIES
Long-Term Debt	$65.01M	$65.50M	$64.30M
YoY Change	-2.7%	1.87%	-24.0%
Other Long-Term Liabilities	$4.133M	$3.785M	$4.346M
YoY Change	12.4%	-12.91%	45.06%
Total Long-Term Liabilities	$69.15M	$3.785M	$4.346M
YoY Change	-1.91%	-12.91%	45.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.50M	$20.53M	$61.33M
Total Long-Term Liabilities	$69.15M	$3.785M	$4.346M
Total Liabilities	$88.68M	$90.03M	$130.4M
YoY Change	-7.61%	-30.94%	-17.0%
SHAREHOLDERS EQUITY
Retained Earnings	-$106.3M	-$107.0M	-$99.17M
YoY Change	6.71%	7.89%	32.99%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$17.87M	$17.17M	-$37.56M
YoY Change
Total Liabilities & Shareholders Equity	$106.6M	$107.2M	$154.3M
YoY Change	-10.83%	-30.53%	-18.85%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	$710.0K	-$766.0K	-$1.988M
YoY Change	-51.37%	-61.47%	-58.68%
Depreciation, Depletion And Amortization	$1.370M	$1.193M	$1.124M
YoY Change	22.32%	6.14%	-41.18%
Cash From Operating Activities	$1.600M	$1.880M	-$700.0K
YoY Change	-158.18%	-368.57%	-87.16%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$240.0K	-$660.0K
YoY Change	-90.0%	-63.64%	8.2%
Acquisitions
YoY Change
Other Investing Activities	$1.910M	-$30.00K	-$230.0K
YoY Change	-89.79%	-86.96%	-102.94%
Cash From Investing Activities	$1.840M	-$270.0K	-$880.0K
YoY Change	-89.73%	-69.32%	-112.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-810.0K	-2.620M	-210.0K
YoY Change	-68.6%	1147.62%	-98.36%
NET CHANGE
Cash From Operating Activities	1.600M	1.880M	-700.0K
Cash From Investing Activities	1.840M	-270.0K	-880.0K
Cash From Financing Activities	-810.0K	-2.620M	-210.0K
Net Change In Cash	2.630M	-1.010M	-1.790M
YoY Change	-79.09%	-43.58%	-83.82%
FREE CASH FLOW
Cash From Operating Activities	$1.600M	$1.880M	-$700.0K
Capital Expenditures	-$80.00K	-$240.0K	-$660.0K
Free Cash Flow	$1.680M	$2.120M	-$40.00K
YoY Change	-186.15%	-5400.0%	-99.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001004724
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19762036	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	REGIONAL HEALTH PROPERTIES, INC
CY2016Q4	rhe	Accrued Payroll Related Expenses Current AccruedPayrollRelatedExpensesCurrent	442000	USD
CY2017Q3	rhe	Accrued Payroll Related Expenses Current AccruedPayrollRelatedExpensesCurrent	387000	USD
CY2016Q4	rhe	Allowance For Uncollectible Accounts Patient Care Receivables AllowanceForUncollectibleAccountsPatientCareReceivables	7500000	USD
CY2017Q3	rhe	Allowance For Uncollectible Accounts Patient Care Receivables AllowanceForUncollectibleAccountsPatientCareReceivables	2900000	USD
CY2017Q3	rhe	Debt Instrument Numberof Credit Related Instruments DebtInstrumentNumberofCreditRelatedInstruments	28	credit_instrument
CY2017Q3	rhe	Debt Instruments Maturities Maturingin Oneand Two Fiscal Years DebtInstrumentsMaturitiesMaturinginOneandTwoFiscalYears	11000000	USD
CY2017Q3	rhe	Debt Long Term And Short Term Combined Amount Before Unamortized Discount Premium DebtLongTermAndShortTermCombinedAmountBeforeUnamortizedDiscountPremium	76049000	USD
CY2016Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	9077000	USD
CY2017Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	8582000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21816000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22644000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	281000	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	890000	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	127000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	281000	USD
CY2016Q4	rhe	Escrow Deposit Current EscrowDepositCurrent	529000	USD
CY2017Q3	rhe	Escrow Deposit Current EscrowDepositCurrent	642000	USD
CY2016Q4	rhe	Long Term Bond Non Current LongTermBondNonCurrent	6586000	USD
CY2017Q3	rhe	Long Term Bond Non Current LongTermBondNonCurrent	6548000	USD
CY2017Q3	rhe	Longterm Debt Maturities Repaymentsof Principalin Next Twelve Months Amortization LongtermDebtMaturitiesRepaymentsofPrincipalinNextTwelveMonthsAmortization	1600000	USD
	rhe	Noncashor Part Noncash Proceedsfrom Financing NoncashorPartNoncashProceedsfromFinancing	0	USD
	rhe	Noncashor Part Noncash Proceedsfrom Financing NoncashorPartNoncashProceedsfromFinancing	385000	USD
	rhe	Noncashor Part Noncash Proceedsfrom Vendor Financed Insurance NoncashorPartNoncashProceedsfromVendorFinancedInsurance	0	USD
	rhe	Noncashor Part Noncash Proceedsfrom Vendor Financed Insurance NoncashorPartNoncashProceedsfromVendorFinancedInsurance	198000	USD
	rhe	Noncashor Part Noncash Surrenderof Security Deposit NoncashorPartNoncashSurrenderofSecurityDeposit	0	USD
	rhe	Noncashor Part Noncash Surrenderof Security Deposit NoncashorPartNoncashSurrenderofSecurityDeposit	500000	USD
CY2017Q3	rhe	Number Of Facilities NumberOfFacilities	30	facility
	rhe	Number Of Sublease Agreements Executed NumberOfSubleaseAgreementsExecuted	27	facility
CY2017Q3	rhe	Numberof Independent Living Facilities NumberofIndependentLivingFacilities	1	facility
CY2017Q3	rhe	Numberof Skilled Nursing Facilities Managedon Behalfof Third Party NumberofSkilledNursingFacilitiesManagedonBehalfofThirdParty	2	facility
CY2017Q3	rhe	Numberof Sublease Agreements Executed Leasedby Company NumberofSubleaseAgreementsExecutedLeasedbyCompany	11	facility
CY2017Q3	rhe	Numberof Sublease Agreements Executed Ownedby Company NumberofSubleaseAgreementsExecutedOwnedbyCompany	14	facility
CY2017Q3	rhe	Operating Lease Escalation Percentage Initial Term Percentage OperatingLeaseEscalationPercentageInitialTermPercentage	0.03
	rhe	Operating Lease Rent Revenue Discount Percentage OperatingLeaseRentRevenueDiscountPercentage	0.5
	rhe	Operating Lease Rent Revenue Periodfor Discounted Rent OperatingLeaseRentRevenuePeriodforDiscountedRent	P5M
	rhe	Operating Lease Rent Revenue Periodfor Dollar One Rent OperatingLeaseRentRevenuePeriodforDollarOneRent	P3M
	rhe	Operating Lease Rent Revenue Property Under Rectification OperatingLeaseRentRevenuePropertyUnderRectification	1	USD
	rhe	Operating Leases Numberof Skilled Nursing Facilities Leased OperatingLeasesNumberofSkilledNursingFacilitiesLeased	11	facility
CY2016Q4	rhe	Replacement Reserves Current ReplacementReservesCurrent	811000	USD
CY2017Q3	rhe	Replacement Reserves Current ReplacementReservesCurrent	278000	USD
CY2016Q4	rhe	Restricted Cashand Cash Equivalent Reservefor Specified Purpose Including Escrow RestrictedCashandCashEquivalentReserveforSpecifiedPurposeIncludingEscrow	1590000	USD
CY2017Q3	rhe	Restricted Cashand Cash Equivalent Reservefor Specified Purpose Including Escrow RestrictedCashandCashEquivalentReserveforSpecifiedPurposeIncludingEscrow	2175000	USD
	rhe	Settlement Agreementsin Excessof Cash Paid SettlementAgreementsinExcessofCashPaid	0	USD
	rhe	Settlement Agreementsin Excessof Cash Paid SettlementAgreementsinExcessofCashPaid	-300000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3037000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	3617000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2429000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1086000	USD
CY2016Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	557000	USD
CY2017Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	435000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7529000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2946000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	614000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	230000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	338000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1176000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	336000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1013000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4516000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2385000	shares
CY2016Q4	us-gaap	Assets Assets	119486000	USD
CY2017Q3	us-gaap	Assets Assets	107199000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	20469000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	4545000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2720000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1457000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14045000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1115000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1263000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12930000	USD
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-1080000	USD
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-485000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-3470000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-961000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2017Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	55000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19927000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19762000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19927000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19762000	shares
CY2016Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	61643000	USD
CY2017Q3	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	61738000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	9136000	USD
CY2017Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1499000	USD
CY2016Q4	us-gaap	Debt Current DebtCurrent	13154000	USD
CY2017Q3	us-gaap	Debt Current DebtCurrent	8327000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	82357000	USD
CY2017Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	76049000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	191000	USD
CY2017Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	181000	USD
CY2017Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	73800000	USD
CY2017Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	73818000	USD
CY2016Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	226000	USD
CY2017Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	226000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	786000	USD
	us-gaap	Depreciation Depreciation	3000000	USD
CY2017Q3	us-gaap	Depreciation Depreciation	857000	USD
	us-gaap	Depreciation Depreciation	2486000	USD
CY2016Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1124000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4176000	USD
CY2017Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1193000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3499000	USD
CY2016Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-2210000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-6513000	USD
CY2017Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-1032000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-2049000	USD
CY2016Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1879000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	5457000	USD
CY2017Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1912000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	5702000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.72
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.13
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7610000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	8623000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32163000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32163000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2754000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2253000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-63000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1598000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6275000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1063000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3507000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	2105000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	2105000	USD
CY2016Q4	us-gaap	Goodwill Gross GoodwillGross	2945000	USD
CY2017Q3	us-gaap	Goodwill Gross GoodwillGross	2945000	USD
CY2016Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	840000	USD
CY2017Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	840000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	225000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2404000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	285000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	371000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	222000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2407000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	266000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	351000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.08
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.39
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.08
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.27
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-6513000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2049000	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.11
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.33
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.05
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.10
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	3000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	13000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-199000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	324000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	657000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-409000	USD
	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	-1941000	USD
	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	-2138000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	630000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	167000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-39000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	16000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-929000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-202000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-3625000	USD
	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-1889000	USD
CY2016Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2471000	USD
CY2017Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2471000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	24553000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23540000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	1801000	USD
	us-gaap	Interest Expense InterestExpense	5377000	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	1011000	USD
	us-gaap	Interest Expense InterestExpense	3049000	USD
	us-gaap	Interest Paid InterestPaid	4846000	USD
	us-gaap	Interest Paid InterestPaid	2840000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	251000	USD
CY2017Q3	us-gaap	Interest Payable Current InterestPayableCurrent	248000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	95987000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	90028000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	119486000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	107199000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25268000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	20526000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	79970000	USD
CY2017Q3	us-gaap	Long Term Debt LongTermDebt	73818000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths	8328000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive	54407000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	5552000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	2088000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	2955000	USD
CY2017Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	2719000	USD
CY2016Q4	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	66816000	USD
CY2017Q3	us-gaap	Long Term Notes And Loans LongTermNotesAndLoans	65491000	USD
CY2016Q3	us-gaap	Management Fees Revenue ManagementFeesRevenue	253000	USD
	us-gaap	Management Fees Revenue ManagementFeesRevenue	760000	USD
CY2017Q3	us-gaap	Management Fees Revenue ManagementFeesRevenue	362000	USD
	us-gaap	Management Fees Revenue ManagementFeesRevenue	1081000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6816000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-16224000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-5736000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-15739000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6217000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-260000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	6217000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-260000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-664000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3554000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2806000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	4515000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-1988000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-8920000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-766000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1698000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3867000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14377000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2678000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7400000	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1801000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5428000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1116000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3500000	USD
CY2016Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	4018000	USD
CY2017Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	6828000	USD
CY2016Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3000000	USD
CY2017Q3	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	3589000	USD
	us-gaap	Notes Issued1 NotesIssued1	0	USD
	us-gaap	Notes Issued1 NotesIssued1	4125000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	5139000	USD
	us-gaap	Operating Expenses OperatingExpenses	18387000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	4944000	USD
	us-gaap	Operating Expenses OperatingExpenses	14913000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2026000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3024000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1401000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	3871000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	82849000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	8830000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	8671000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	8492000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8331000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	46456000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	234503000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	23886000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	23299000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	22764000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	22281000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsReceivableRemainderOfFiscalYear	5460000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	136813000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	2069000	USD
CY2016Q3	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	6912000	USD
	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	20651000	USD
CY2017Q3	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	5983000	USD
	us-gaap	Operating Leases Income Statement Minimum Lease Revenue OperatingLeasesIncomeStatementMinimumLeaseRevenue	17703000	USD
CY2016Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2176000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6523000	USD
CY2017Q3	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2171000	USD
	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6512000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	903000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	829000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4244000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6407000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3677000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3785000	USD
CY2016Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	41000	USD
CY2017Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	731000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-105000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-388000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	312000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	186000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	116000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5457000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5702000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	704000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	774000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	1375000	USD
CY2016Q4	us-gaap	Pledged Assets Not Separately Reported Other Financial Instruments PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments	260000	USD
CY2017Q3	us-gaap	Pledged Assets Not Separately Reported Other Financial Instruments PledgedAssetsNotSeparatelyReportedOtherFinancialInstruments	40000	USD
CY2016Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2017Q3	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2016Q4	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	69038000	USD
CY2017Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	70288000	USD
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2762000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2812000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2762000	shares
	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	0	USD
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2812000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	61446000	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	62423000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2395000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1384000	USD
	us-gaap	Proceeds From Deposits With Other Institutions ProceedsFromDepositsWithOtherInstitutions	1750000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	6790000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	977000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	3940000	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	8300000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1546000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Profit Loss ProfitLoss	-1698000	USD
	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	2200000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	100984000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105085000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79168000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	82441000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	455000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	721000	USD
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	440000	USD
	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	62423000	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	7700000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10496000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3038000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	85000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	90000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1600000	USD
CY2017Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	960000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	5464000	USD
CY2017Q3	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	3540000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	1600000	USD
CY2017Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	960000	USD
CY2016Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	3864000	USD
CY2017Q3	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	2580000	USD
CY2016Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	2274000	USD
CY2017Q3	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	405000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99590000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-106990000	USD
CY2016Q3	us-gaap	Revenues Revenues	7165000	USD
	us-gaap	Revenues Revenues	21411000	USD
CY2017Q3	us-gaap	Revenues Revenues	6345000	USD
	us-gaap	Revenues Revenues	18784000	USD
CY2016Q4	us-gaap	Security Deposit SecurityDeposit	1411000	USD
CY2017Q3	us-gaap	Security Deposit SecurityDeposit	808000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.41
	us-gaap	Severance Costs1 SeveranceCosts1	1395000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	890000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	281000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	6924000	USD
CY2017Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	6683000	USD
CY2016Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	60189000	USD
CY2017Q3	us-gaap	Senior Long Term Notes SeniorLongTermNotes	58212000	USD
CY2016Q3	us-gaap	Severance Costs1 SeveranceCosts1	241000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	1413000	USD
CY2017Q3	us-gaap	Severance Costs1 SeveranceCosts1	517000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0143
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0000
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	594179	shares
CY2017Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	210000	shares
CY2017Q3	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	245000	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.41
CY2017Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.48
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P5Y10M01D
CY2017Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	8300000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	186000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-37947000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	17171000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-37947000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17171000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2196000	USD
CY2017Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	2050000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19917000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19909000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19762000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19784000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19917000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19909000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19762000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19784000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19917000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19909000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19762000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19784000	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported results of operations during the reporting period. Examples of significant estimates include allowance for doubtful accounts, self-insurance reserves, deferred tax valuation allowance, fair value of employee and nonemployee stock based awards, valuation of goodwill and other long-lived assets, and cash flow projections. Actual results could differ materially from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001004724-17-000078-index-headers.html	Edgar Link	pending
0001004724-17-000078-index.html	Edgar Link	pending
0001004724-17-000078.txt	Edgar Link	pending
0001004724-17-000078-xbrl.zip	Edgar Link	pending
a09302017-documentx10q.htm	Edgar Link	pending
a09302017-ex311.htm	Edgar Link	pending
a09302017-ex312.htm	Edgar Link	pending
a09302017-ex321.htm	Edgar Link	pending
a09302017-ex322.htm	Edgar Link	pending
a1010exchangebank001.jpg	Edgar Link	pending
a1010exchangebank002.jpg	Edgar Link	pending
a1010exchangebank003.jpg	Edgar Link	pending
a1010exchangebank004.jpg	Edgar Link	pending
a1010exchangebank005.jpg	Edgar Link	pending
a1010exchangebank006.jpg	Edgar Link	pending
a1011covingtoncareandgre001.jpg	Edgar Link	pending
a1011covingtoncareandgre002.jpg	Edgar Link	pending
a1011covingtoncareandgre003.jpg	Edgar Link	pending
a1012omegaleasemergercon001.jpg	Edgar Link	pending
a1012omegaleasemergercon002.jpg	Edgar Link	pending
a1012omegaleasemergercon003.jpg	Edgar Link	pending
a108billmcbridesettlemen001.jpg	Edgar Link	pending
a108billmcbridesettlemen002.jpg	Edgar Link	pending
a108billmcbridesettlemen003.jpg	Edgar Link	pending
a108billmcbridesettlemen004.jpg	Edgar Link	pending
a108billmcbridesettlemen005.jpg	Edgar Link	pending
a108billmcbridesettlemen006.jpg	Edgar Link	pending
a108billmcbridesettlemen007.jpg	Edgar Link	pending
a108billmcbridesettlemen008.jpg	Edgar Link	pending
a108billmcbridesettlemen009.jpg	Edgar Link	pending
a108billmcbridesettlemen010.jpg	Edgar Link	pending
a108billmcbridesettlemen011.jpg	Edgar Link	pending
a108billmcbridesettlemen012.jpg	Edgar Link	pending
a108billmcbridesettlemen013.jpg	Edgar Link	pending
a108billmcbridesettlemen014.jpg	Edgar Link	pending
a108billmcbridesettlemen015.jpg	Edgar Link	pending
a109congressionaljoinder001.jpg	Edgar Link	pending
a109congressionaljoinder002.jpg	Edgar Link	pending
a109congressionaljoinder003.jpg	Edgar Link	pending
a109congressionaljoinder004.jpg	Edgar Link	pending
a109congressionaljoinder005.jpg	Edgar Link	pending
a109congressionaljoinder006.jpg	Edgar Link	pending
a109congressionaljoinder007.jpg	Edgar Link	pending
a109congressionaljoinder008.jpg	Edgar Link	pending
a109congressionaljoinder009.jpg	Edgar Link	pending
a109congressionaljoinder010.jpg	Edgar Link	pending
a109congressionaljoinder011.jpg	Edgar Link	pending
a109congressionaljoinder012.jpg	Edgar Link	pending
a109congressionaljoinder013.jpg	Edgar Link	pending
a109congressionaljoinder014.jpg	Edgar Link	pending
a109congressionaljoinder015.jpg	Edgar Link	pending
a109congressionaljoinder016.jpg	Edgar Link	pending
a109congressionaljoinder017.jpg	Edgar Link	pending
a109congressionaljoinder018.jpg	Edgar Link	pending
a109congressionaljoinder019.jpg	Edgar Link	pending
a109congressionaljoinder020.jpg	Edgar Link	pending
a109congressionaljoinder021.jpg	Edgar Link	pending
a109congressionaljoinder022.jpg	Edgar Link	pending
a109congressionaljoinder023.jpg	Edgar Link	pending
a109congressionaljoinder024.jpg	Edgar Link	pending
a109congressionaljoinder025.jpg	Edgar Link	pending
a109congressionaljoinder026.jpg	Edgar Link	pending
a109congressionaljoinder027.jpg	Edgar Link	pending
a109congressionaljoinder028.jpg	Edgar Link	pending
a109congressionaljoinder029.jpg	Edgar Link	pending
ex1012omegaleaseconsent.htm	Edgar Link	pending
a109congressionaljoinder030.jpg	Edgar Link	pending
a109congressionaljoinder031.jpg	Edgar Link	pending
a109congressionaljoinder032.jpg	Edgar Link	pending
a109congressionaljoinder033.jpg	Edgar Link	pending
a109congressionaljoinder034.jpg	Edgar Link	pending
a109congressionaljoinder035.jpg	Edgar Link	pending
a416rhecantone6monthexte001.jpg	Edgar Link	pending
a416rhecantone6monthexte002.jpg	Edgar Link	pending
a416rhecantone6monthexte003.jpg	Edgar Link	pending
a416rhecantone6monthexte004.jpg	Edgar Link	pending
a416rhecantone6monthexte005.jpg	Edgar Link	pending
a417mcbridenoteexecuted1001.jpg	Edgar Link	pending
a417mcbridenoteexecuted1002.jpg	Edgar Link	pending
a417mcbridenoteexecuted1003.jpg	Edgar Link	pending
a417mcbridenoteexecuted1004.jpg	Edgar Link	pending
a417mcbridenoteexecuted1005.jpg	Edgar Link	pending
ex1010exchangebankjoinder.htm	Edgar Link	pending
ex1011covingtonconsent.htm	Edgar Link	pending
ex108mcbridesettlement.htm	Edgar Link	pending
ex109congressionaljoinder.htm	Edgar Link	pending
ex416convertnote.htm	Edgar Link	pending
ex417mcbridenote.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rhe-20170930.xml	Edgar Link	completed
rhe-20170930.xsd	Edgar Link	pending
rhe-20170930_cal.xml	Edgar Link	unprocessable
rhe-20170930_def.xml	Edgar Link	unprocessable
rhe-20170930_lab.xml	Edgar Link	unprocessable
rhe-20170930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RHE
Regional Health Properties Inc Stock $rhe

2017 Q4 Form 10-Q Financial Statement

#000100472417000078 Filed on November 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RHE Regional Health Properties Inc Stock $rhe

2017 Q4 Form 10-Q Financial Statement

#000100472417000078 Filed on November 14, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RHE
Regional Health Properties Inc Stock $rhe